169 related articles for article (PubMed ID: 9010024)
21. Loss of heterozygosity is related to p53 mutations and smoking in lung cancer.
Zienolddiny S; Ryberg D; Arab MO; Skaug V; Haugen A
Br J Cancer; 2001 Jan; 84(2):226-31. PubMed ID: 11161381
[TBL] [Abstract][Full Text] [Related]
22. [Prognostic value of heterozygosity loss in chromosome 3p in non-microcytic bronchogenic carcinoma].
Maestro ML; Izquierdo L; Sánchez-Pernaute A; Sanz Casla MT; González S; Torres A; del Barco V; Gómez A; Pérez Aguirre E; Balibrea JL
Med Clin (Barc); 1999 Apr; 112(14):527-9. PubMed ID: 10363238
[TBL] [Abstract][Full Text] [Related]
23. Frequent microsatellite alterations on chromosome 3p in esophageal squamous cell carcinoma.
Ogasawara S; Maesawa C; Tamura G; Satodate R
Cancer Res; 1995 Feb; 55(4):891-4. PubMed ID: 7850805
[TBL] [Abstract][Full Text] [Related]
24. Loss of heterozygosity at 3p in non-small cell lung cancer and its prognostic implication.
Mitsudomi T; Oyama T; Nishida K; Ogami A; Osaki T; Sugio K; Yasumoto K; Sugimachi K; Gazdar AF
Clin Cancer Res; 1996 Jul; 2(7):1185-9. PubMed ID: 9816286
[TBL] [Abstract][Full Text] [Related]
25. Plasma DNA, microsatellite alterations, and p53 tumor mutations are associated with disease-free survival in radically resected non-small cell lung cancer patients: a study of the perugia multidisciplinary team for thoracic oncology.
Ludovini V; Pistola L; Gregorc V; Floriani I; Rulli E; Piattoni S; Di Carlo L; Semeraro A; Darwish S; Tofanetti FR; Stocchi L; Mihaylova Z; Bellezza G; Del Sordo R; Daddi G; Crinò L; Tonato M
J Thorac Oncol; 2008 Apr; 3(4):365-73. PubMed ID: 18379354
[TBL] [Abstract][Full Text] [Related]
26. Loss of heterozygosity on chromosomes 2p, 3p, 18q21.3 and 11p15.5 as a poor prognostic factor in stage II and III (FIGO) cervical cancer treated by radiotherapy.
Kozlowski L; Filipowski T; Rucinska M; Pepinski W; Janica J; Skawronska M; Poznanski J; Wojtukiewicz MZ
Neoplasma; 2006; 53(5):440-3. PubMed ID: 17013540
[TBL] [Abstract][Full Text] [Related]
27. Detection of chromosome 3p alterations in serum DNA of non-small-cell lung cancer patients.
Sánchez-Céspedes M; Monzó M; Rosell R; Pifarré A; Calvo R; López-Cabrerizo MP; Astudillo J
Ann Oncol; 1998 Jan; 9(1):113-6. PubMed ID: 9541693
[TBL] [Abstract][Full Text] [Related]
28. Microsatellite alterations at 5q21, 11p13, and 11p15.5 do not predict survival in non-small cell lung cancer.
Sánchez-Céspedes M; Rosell R; Pifarré A; López-Cabrerizo MP; Barnadas A; Sánchez JJ; Lorenzo JC; Abad A; Monzó M; Navas-Palacios JJ
Clin Cancer Res; 1997 Jul; 3(7):1229-35. PubMed ID: 9815804
[TBL] [Abstract][Full Text] [Related]
29. Allelic loss on chromosomes 3p, 5q and 17p in renal cell carcinomas.
Sugimura J; Tamura G; Suzuki Y; Fujioka T
Pathol Int; 1997; 47(2-3):79-83. PubMed ID: 9088024
[TBL] [Abstract][Full Text] [Related]
30. Microsatellite instability and loss of heterozygosity at chromosomes 9 and 17 in non-small cell lung cancer.
Froudarakis ME; Sourvinos G; Fournel P; Bouros D; Vergnon JM; Spandidos DA; Siafakas NM
Chest; 1998 Apr; 113(4):1091-4. PubMed ID: 9554652
[TBL] [Abstract][Full Text] [Related]
31. Microsatellite alteration at chromosome 3p loci in neuroendocrine and non-neuroendocrine lung tumors. Histogenetic and clinical relevance.
Hurr K; Kemp B; Silver SA; el-Naggar AK
Am J Pathol; 1996 Aug; 149(2):613-20. PubMed ID: 8701999
[TBL] [Abstract][Full Text] [Related]
32. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
Singh RB; Amare Kadam PS
Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
[TBL] [Abstract][Full Text] [Related]
33. Replication error in human breast cancer: comparison with clinical variables and family history of cancer.
Huiping C; Johannsdottir JT; Arason A; Olafsdottir GH; Eiriksdottir G; Egilsson V; Ingvarsson S
Oncol Rep; 1999; 6(1):117-22. PubMed ID: 9864413
[TBL] [Abstract][Full Text] [Related]
34. Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC).
Lim EH; Zhang SL; Li JL; Yap WS; Howe TC; Tan BP; Lee YS; Wong D; Khoo KL; Seto KY; Tan L; Agasthian T; Koong HN; Tam J; Tan C; Caleb M; Chang A; Ng A; Tan P
J Thorac Oncol; 2009 Jan; 4(1):12-21. PubMed ID: 19096301
[TBL] [Abstract][Full Text] [Related]
35. Molecular staging of non-small cell lung cancer according to K-ras genotypes.
Rosell R; Monzó M; Pifarré A; Ariza A; Sánchez JJ; Moreno I; Maurel J; López MP; Abad A; de Anta JM
Clin Cancer Res; 1996 Jun; 2(6):1083-6. PubMed ID: 9816271
[TBL] [Abstract][Full Text] [Related]
36. Frequency and prognostic evaluation of 3p21-22 allelic losses in non-small-cell lung cancer.
Thiberville L; Bourguignon J; Metayer J; Bost F; Diarra-Mehrpour M; Bignon J; Lam S; Martin JP; Nouvet G
Int J Cancer; 1995 Dec; 64(6):371-7. PubMed ID: 8550237
[TBL] [Abstract][Full Text] [Related]
37. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer.
Huang C; Taki T; Adachi M; Konishi T; Higashiyama M; Miyake M
Oncogene; 1998 May; 16(19):2469-77. PubMed ID: 9627113
[TBL] [Abstract][Full Text] [Related]
38. Allelotype and replication error phenotype of small cell lung carcinoma.
Kawanishi M; Kohno T; Otsuka T; Adachi J; Sone S; Noguchi M; Hirohashi S; Yokota J
Carcinogenesis; 1997 Nov; 18(11):2057-62. PubMed ID: 9395202
[TBL] [Abstract][Full Text] [Related]
39. p16(INK4A) Hypermethylation detected by fluorescent methylation-specific PCR in plasmas from non-small cell lung cancer.
Bearzatto A; Conte D; Frattini M; Zaffaroni N; Andriani F; Balestra D; Tavecchio L; Daidone MG; Sozzi G
Clin Cancer Res; 2002 Dec; 8(12):3782-7. PubMed ID: 12473590
[TBL] [Abstract][Full Text] [Related]
40. Pancreatic adenocarcinomas with DNA replication errors (RER+) are associated with wild-type K-ras and characteristic histopathology. Poor differentiation, a syncytial growth pattern, and pushing borders suggest RER+.
Goggins M; Offerhaus GJ; Hilgers W; Griffin CA; Shekher M; Tang D; Sohn TA; Yeo CJ; Kern SE; Hruban RH
Am J Pathol; 1998 Jun; 152(6):1501-7. PubMed ID: 9626054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
